Buy & Sell Automatic Data Processing Inc (ADP) – Automatic Data Processing Inc Price Today
Aura AI Summary
Key Stats
- $82.82BMarket Cap
- IndustrialsSector
- -16.69%3M Drawdown
- $83.89BEnterprise Value
- 3.28%Dividend Yield
- 2% Buy | 98% SellTrading Activity
- 75 daysTypical Hold Time
Automatic Data Processing Inc (ADP) is currently valued at a market capitalization of $82.82B, with an enterprise value of $83.89B. Over the past 52 weeks, Automatic Data Processing Inc has traded between a low of $188.79 and a high of $326.81, highlighting its annual price range. Over the past three months, Automatic Data Processing Inc has recorded a drawdown of -16.69%, reflecting recent price volatility. Automatic Data Processing Inc offers a dividend yield of 3.28%, with the most recent dividend of $1.70 paid on 13 Mar 26. On average, investors hold Automatic Data Processing Inc for approximately 75 days, indicating typical investor behavior on the platform.
About Automatic Data Processing Inc
ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.
Most Recent News
CallPhantom scam apps on Google Play fake call logs but charge real money, downloaded 7.3M+ times.
ESET researchers uncovered 28 fraudulent Android apps named CallPhantom on Google Play that falsely claim to provide call logs, SMS, and WhatsApp history for any phone number in exchange for payment. These apps, downloaded over 7.3 million times, gen...
Oculis secures FDA agreement on trial design for Privosegtor in optic neuritis treatment
Oculis Holding AG has received FDA Special Protocol Assessment (SPA) approval for its Phase 3 PIONEER-1 trial of Privosegtor, a novel neuroprotective drug for optic neuritis (ON). This agreement confirms the trial design is suitable to support a futu...
Microsoft seen as undervalued despite strong Q3 growth and rising AI revenue, market fixates on CapEx concerns.
Microsoft is currently trading at less than 20 times forward earnings, which many see as undervalued given its strong operational performance and a $627 billion contracted backlog. In its Q3 report, Microsoft beat expectations on both revenue and pro...